Brown, Victoria
Merikle, Elizabeth
Johnston, Kelly
Gooch, Katherine
Audhya, Ivana
Lowes, Linda
Funding for this research was provided by:
Sarepta Therapeutics
Article History
Received: 28 October 2022
Accepted: 27 November 2023
First Online: 12 December 2023
Declarations
:
: This study was reviewed and approved by the NCH Hospital Internal Review Board.
: Not applicable.
: VB, EM, and KJ are employees of Fortrea Inc. (formerly Labcorp Drug Development Inc.), which was funded by Sarepta Therapeutics, Inc., to conduct the interviews. KG and IA are employees of Sarepta Therapeutics, Inc., and may own stock/options. LL recruited and screened patients for this study; she is an employee of NCH, which receives grant funding for other research initiatives from Sarepta Therapeutics, Inc.